Current research on head and neck cancer-associated long noncoding RNAs

Oncotarget

Volumn 9, Issue 1, 2018, Pages 1403-1425

  Song, Wei ^a   Sun, Yimin ^a   Lin, Jie ^a   Bi, Xiaoqin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cancer progression; Clinical implication; Head and neck cancer; Long noncoding RNA

Indexed keywords

ACTIN FILAMENT ASSOCIATED PROTEIN 1 ANTISENSE RNA1; ANTISENSE NONCODING RNA IN THE INK4 LOCUS; BRAF ACTIVATED NONCODING RNA; FERRITIN HEAVY CHAIN 1 PSEUDOGENE 3; FOCALLY AMPLIFIED LONG NONCODING RNA ON CHROMOSOME 1; FOXC1 UPSTREAM TRANSCRIPT; GROWTH ARREST SPECIFIC 8 ANTISENSE RNA 1; HEAD AND NECK SQUAMOUS CELL CARCINOMA GLYCOLYSIS ASSOCIATED 1; HOX TRANSCRIPT ANTISENSE RNA; LONG UNTRANSLATED RNA; MATERNALLY EXPRESSED GENE 3; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; MITOGEN ACTIVATED PROTEIN KINASE PATHWAY AND GROWTH ARREST; NUCLEAR ENRICHED ABUNDANT TRANSCRIPT 1; NUCLEAR FACTOR KAPPA B INTERACTING LONG NONCODING RNA; PAPILLARY THYROID CANCER SUSCEPTIBILITY CANDIDATE; PAPILLARY THYROID CANCER SUSCEPTIBILITY CANDIDATE 1; PAPILLARY THYROID CANCER SUSCEPTIBILITY CANDIDATE 2; PAPILLARY THYROID CANCER SUSCEPTIBILITY CANDIDATE 3; RNA H19; RNA LET; RNA LINC00673; RNA LINC0086; RNA LOC401317; RNA PANCR; RNA PTENP1; RNA PVT1; RNA ROR; UNCLASSIFIED DRUG; UROTHELIAL CANCER ASSOCIATED 1;

CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; GENE EXPRESSION; GENETIC ASSOCIATION; HEAD AND NECK CANCER; HEAD AND NECK CARCINOMA; HUMAN; HYPOPHARYNX SQUAMOUS CELL CARCINOMA; LARYNX SQUAMOUS CELL CARCINOMA; MOUTH SQUAMOUS CELL CARCINOMA; NASOPHARYNX CARCINOMA; REVIEW; THYROID CANCER; TONGUE CARCINOMA;

EID: 85039841380     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.22608     Document Type: Review

References (180)

1. Petersson F. Nasopharyngeal carcinoma: A review. Semin Diagn Pathol. 2015; 32:54-73. https://doi.org/10.1053/j. semdp.2015.02.021
2. Metcalfe CW, Lowe D, Rogers SN. What patients consider important: temporal variations by early and late stage oral, oropharyngeal and laryngeal subsites. J Craniomaxillofac Surg. 2014; 42:641-7. https://doi.org/10.1016/j.jcms.2013.09.008
3. Rettig EM, D'Souza G. Epidemiology of Head and Neck Cancer. Surgical Oncology Clinics of North America. 2015; 24:379-96. http://doi.org/10.1016/j.soc.2015.03.001
4. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet. 2008; 371:1695-709
5. Belcher R, Hayes K, Fedewa S, Chen AY. Current treatment of head and neck squamous cell cancer. Journal of Surgical Oncology. 2014; 110:551-74. https://doi.org/10.1002/jso.23724
6. Boffetta P, Hashibe M, INHANCE Consortium OBO. Alcohol drinking in never-tobacco users and cigarette smoking in never drinkers: pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Cancer Research. 2007; 67:863
7. Leemans CR, Braakhuis BJ, Brakenhoff RH. Response to correspondence on the molecular biology of head and neck cancer. Nat Rev Cancer. 2011; 11:382
8. Mao L, Hong WK, Papadimitrakopoulou VA. Focus on head and neck cancer. Cancer Cell. 2004; 5:311-6. http:// doi.org/10.1016/S1535-6108(04)00090-X
9. Spence T, Bruce J, Yip K, Liu FF. HPV Associated Head and Neck Cancer. Cancers. 2016; 8:75
10. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45: 309-316. Oral Oncology. 2008; 45:309-16
11. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011; 61:212
12. Almadori G, Bussu F, Cadoni G, Galli J, Paludetti G, Maurizi M. Molecular markers in laryngeal squamous cell carcinoma: Towards an integrated clinicobiological approach. European Journal of Cancer. 2005; 41:683-93
13. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007; 57:43-66
14. Patel RS, Clark JR, Dirven R, Wyten R, Gao K, O'Brien CJ. Prognostic factors in the surgical treatment of patients with oral carcinoma. ANZ journal of surgery. 2009; 79:19-22
15. Franceschi D, Gupta R, Spiro RH, Shah JP. Improved survival in the treatment of squamous carcinoma of the oral tongue. The American Journal of Surgery. 1993; 166:360-5
16. Hall SF, Groome PA, Irish J, O'Sullivan B. The natural history of patients with squamous cell carcinoma of the hypopharynx. Laryngoscope. 2008; 118:1362
17. Lehnerdt GF, Franz P, Zaqoul A, Schmitz KJ, Grehl S, Lang S, Schmid KW, Siffert W, Jahnke K, Frey UH. Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene. Clinical Cancer Research. 2008; 14:1753-8
18. Lim YC, Park HY, Hwang HS, Kang SU, Pyun JH, Lee MH, Choi EC, Kim CH. (-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells. Cancer letters. 2008; 271:140-52
19. Davies L, Welch HG. Epidemiology of head and neck cancer in the United States. Otolaryngology-Head and Neck Surgery. 2006; 135:451-7. e3
20. Lothaire P, de Azambuja E, Dequanter D, Lalami Y, Sotiriou C, Andry G, Castro G, Awada A. Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation. Head & neck. 2006; 28:256-69
21. Tang LL, Chen WQ, Xue WQ, He YQ, Zheng RS, Zeng YX, Jia WH. Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer letters. 2016; 374:22-30
22. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61:69-90
23. Marks JE, Phillips JL, Menck HR. The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer. 1998; 83:582-8
24. Wu A, Wu K, Li J, Mo Y, Lin Y, Wang Y, Shen X, Li S, Li L, Yang Z. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma. Journal of translational medicine. 2015; 13:105
25. Wei WI, Sham JS. Nasopharyngeal carcinoma. The Lancet. 2005; 365:2041-54
26. Xing M. Molecular pathogenesis and mechanisms of thyroid cancer. Nature Reviews Cancer. 2013; 13:184-99
27. Board PATE. Thyroid Cancer Treatment (PDQ®). 2016
28. Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Sonis ST, Elad S, Hamblin MR, Barasch A, Migliorati CA, Milstein DM, Genot MT, Lansaat L, van der Brink R, et al. Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations. Supportive Care in Cancer. 2016; 24:2781-92. https://doi.org/10.1007/s00520-016-3152-z
29. Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Elad S, Hamblin MR, Barasch A, Migliorati CA, Milstein DM, Genot MT, Lansaat L, van der Brink R, Arnabat-Dominguez J, et al. Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols. Supportive Care in Cancer. 2016; 24:2793-805. https://doi.org/10.1007/s00520-016-3153-y
30. Dunne S, Mooney O, Coffey L, Sharp L, Desmond D, Timon C, O'Sullivan E, Gallagher P. Psychological variables associated with quality of life following primary treatment for head and neck cancer: a systematic review of the literature from 2004 to 2015. Psycho-Oncology. 2017; 26:149-60. https://doi.org/10.1002/pon.4109
31. Elham R, Selena ZK, Weg MO. Evaluation of Non-Coding RNAs as Potential Targets in Head and Neck Squamous Cell Carcinoma Cancer Stem Cells. Current Drug Targets. 2014; 15:1247-60. https://doi.org/10.2174/1389450115666 141024113446
32. Schmitz SU, Grote P, Herrmann BG. Mechanisms of long noncoding RNA function in development and disease. Cellular and Molecular Life Sciences. 2016; 73:2491-509. https://doi.org/10.1007/s00018-016-2174-5
33. Mercer TR, Dinger ME, Sunkin SM, Mehler MF, Mattick JS. Specific expression of long noncoding RNAs in the mouse brain. Proceedings of the National Academy of Sciences. 2008; 105:716-21. https://doi.org/10.1073/ pnas.0706729105
34. Zou AE, Ku J, Honda TK, Yu V, Kuo SZ, Zheng H, Xuan Y, Saad MA, Hinton A, Brumund KT, Lin JH, Wang-Rodriguez J, Ongkeko WM. Transcriptome sequencing uncovers novel long noncoding and small nucleolar RNAs dysregulated in head and neck squamous cell carcinoma. RNA. 2015; 21:1122-34. https://doi.org/10.1261/ rna.049262.114
35. Yang QQ, Deng YF. Long non-coding RNAs as novel biomarkers and therapeutic targets in head and neck cancers. Int J Clin Exp Pathol. 2014; 1286-92
36. Gutschner T, Diederichs S. The hallmarks of cancer. RNA Biology. 2012; 9:703-19. https://doi.org/10.4161/rna.20481
37. Zou AE, Zheng H, Saad MA, Rahimy M, Ku J, Kuo SZ, Honda TK, Wang-Rodriguez J, Xuan Y, Korrapati A, Yu V, Singh P, Grandis JR, et al. The non-coding landscape of head and neck squamous cell carcinoma. Oncotarget. 2016; 7:51211-22. https://doi.org/10.18632/oncotarget.9979
38. Fayda M, Isin M, Tambas M, Guveli M, Meral R, Altun M, Sahin D, Ozkan G, Sanli Y, Isin H, Ozgur E, Gezer U. Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy? Tumor Biology. 2016; 37:3969-78. https://doi.org/10.1007/s13277-015-4189-1
39. Chen FJ, Sun M, Li SQ, Wu QQ, Ji L, Liu ZL, Zhou GZ, Cao G, Jin L, Xie HW, Wang CM, Lv J, De W, et al. Upregulation of the long non-coding rna hotair promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Molecular Carcinogenesis. 2013; 52:908-15. https://doi.org/10.1002/mc.21944
40. Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, Miyano S, Mori M. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Research. 2011; 71:6320
41. Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, Kim S, Safe S. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene. 2013; 32:1616-25. https://doi.org/http://www. nature.com/onc/journal/v32/n13/suppinfo/onc2012193s1.html
42. Kong L, Zhou X, Wu Y, Wang Y, Chen L, Li P, Liu S, Sun S, Ren Y, Mei M, Wang X, Zhang L. Targeting HOTAIR induces mitochondria related apoptosis and inhibits tumor growth in head and neck squamous cell carcinoma in vitro and in vivo. Curr Mol Med. 2015; 15:952-60. https://doi.or g/10.2174/1566524016666151123112716
43. Xu CZ, Jiang C, Wu Q, Liu L, Yan X, Shi R. A Feed-Forward Regulatory Loop between HuR and the Long Noncoding RNA HOTAIR Promotes Head and Neck Squamous Cell Carcinoma Progression and Metastasis. Cell Physiol Biochem. 2016; 40:1039-51
44. Jakstaite A, Maziukiene A, Silkuniene G, Kmieliute K, Gulbinas A, Dambrauskas Z. HuR mediated posttranscriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancer. World Journal of Gastroenterology. 2015; 21:13004-19. https://doi.org/10.3748/wjg.v21.i46.13004
45. Pachnis V, Brannan CI, Tilghman SM. The structure and expression of a novel gene activated in early mouse embryogenesis. The EMBO Journal. 1988; 7:673-81
46. Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, Galun E. The H19 Non-Coding RNA Is Essential for Human Tumor Growth. Plos One. 2007; 2:e845. https://doi.org/10.1371/journal.pone.0000845
47. Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, Tsao MS, Penn LZ. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer research. 2006; 66:5330-7. https://doi.org/10.1158/0008-5472.can-06-0037
48. Zhang E, Li W, Yin D, De W, Zhu L, Sun S, Han L. c-Mycregulated long non-coding RNA H19 indicates a poor prognosis and affects cell proliferation in non-small-cell lung cancer. Tumour Biol. 2016; 37:4007-15. https://doi. org/10.1007/s13277-015-4185-5
49. El-Naggar AK, Lai S, Tucker SA, Clayman GL, Goepfert H, Hong WK, Huff V. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma. Oncogene. 1999; 18:7063
50. Coutinho-Camillo CM, Brentani MM, Butugan O, Torloni H, Nagai MA. Relaxation of imprinting of IGFII gene in juvenile nasopharyngeal angiofibromas. Diagn Mol Pathol. 2003; 12:57-62. https://doi.org/10.1097/00019606-200303000-00008
51. Guan GF, Zhang DJ, Wen LJ, Xin D, Liu Y, Yu DJ, Su K, Zhu L, Guo YY, Wang K. Overexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinoma. Int J Med Sci. 2016; 13:914-22
52. Wang Y. Upregulated lncRNA-HNGA1, a target of miR-375, contributes to aerobic glycolysis of head and neck squamous cell carcinoma through increasing levels of the glucose transporter protein SCL2A1. European Journal of Cancer. 2016; 61:S14-S5
53. Wang Y, Cheng B. Abstract A42: LncRNA-p23154-miR-375 axis regulates OSCC glycolysis by targeting SCL2A1. AACR. 2016
54. Dahia PL, Fitzgerald MG, Zhang X, Marsh DJ, Zheng Z, Pietsch T, Von DA, Haluska FG, Haber DA, Eng C. A highly conserved processed PTEN pseudogene is located on chromosome band 9p21. Oncogene. 1998; 16:2403-6
55. Liu J, Yue X, Xu L, Chen W, Wei C, Zhang C. Decreased expression of pseudogenePTENP1promotes malignant behaviours and is associated with the poor survival of patients with HNSCC. Scientific Reports. 2017; 7:41179
56. Gore-Panter SR, Hsu J, Barnard J, Moravec CS, Van Wagoner DR, Chung MK, Smith JD. PANCR, the PITX2 Adjacent Noncoding RNA, Is Expressed in Human Left Atria and Regulates PITX2c Expression. Circulation Arrhythmia and electrophysiology. 2016; 9:e003197. https://doi.org/10.1161/CIRCEP.115.003197
57. Quentien MH, Barlier A, Franc JL, Pellegrini I, Brue T, Enjalbert A. Pituitary transcription factors: from congenital deficiencies to gene therapy. J Neuroendocrinol. 2006; 18:633-42. https://doi.org/10.1111/j.1365-2826.2006.01461.x
58. Weiss G, Cottrell S, Distler J, Schatz P, Kristiansen G, Ittmann M, Haefliger C, Lesche R, Hartmann A, Corman J, Wheeler T. DNA methylation of the PITX2 gene promoter region is a strong independent prognostic marker of biochemical recurrence in patients with prostate cancer after radical prostatectomy. J Urol. 2009; 181:1678-85. https:// doi.org/10.1016/j.juro.2008.11.120
59. Banez LL, Sun L, van Leenders GJ, Wheeler TM, Bangma CH, Freedland SJ, Ittmann MM, Lark AL, Madden JF, Hartman A, Weiss G, Castanos-Velez E. Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer. J Urol. 2010; 184:149-56. https://doi.org/10.1016/j.juro.2010.03.012
60. Fung FK, Chan DW, Liu VW, Leung TH, Cheung AN, Ngan HY. Increased expression of PITX2 transcription factor contributes to ovarian cancer progression. PLoS One. 2012; 7:e37076. https://doi.org/10.1371/journal.pone.0037076
61. Sailer V, Holmes EE, Gevensleben H, Goltz D, Droge F, de Vos L, Franzen A, Schrock F, Bootz F, Kristiansen G, Schrock A, Dietrich D. PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma. Oncotarget. 2016; 7:75827-38. https://doi.org/10.18632/ oncotarget.12417
62. Méry B, Rancoule C, Guy JB, Espenel S, Wozny AS, Battiston-Montagne P, Ardail D, Beuve M, Alphonse G, Rodriguez-Lafrasse C, Magné N. Preclinical models in HNSCC: A comprehensive review. Oral Oncol. 2017; 65:51-6. https://doi.org/10.1016/j.oraloncology.2016.12.010
63. Esteves LI, Javaroni AC, Nishimoto IN, Magrin J, Squire JA, Kowalski LP, Rainho CA, Rogatto SR. DNA methylation in the CTCF-binding site I and the expression pattern of the H19 gene: does positive expression predict poor prognosis in early stage head and neck carcinomas? Molecular Carcinogenesis. 2005; 44:102-10
64. Nie Y, Liu X, Qu S, Song E, Zou H, Gong C. Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival. Cancer Science. 2013; 104:458-64. https://doi.org/10.1111/cas.12092
65. Fu WM, Lu YF, Hu BG, Liang WC, Zhu X, Yang HD, Li G, Zhang JF. Long noncoding RNA Hotair mediated angiogenesis in nasopharyngeal carcinoma by direct and indirect signaling pathways. Oncotarget. 2016; 7:4712-23. https://doi.org/10.18632/oncotarget.6731
66. Ng A, Tang JP, Goh CH, Hui KM. Regulation of the H19 imprinting gene expression in human nasopharyngeal carcinoma by methylation. Int J Cancer. 2003; 104:179-87. https://doi.org/10.1002/ijc.10926
67. Li X, Lin Y, Yang X, Wu X, He X. Long noncoding RNA H19 regulates EZH2 expression by interacting with miR-630 and promotes cell invasion in nasopharyngeal carcinoma. Biochemical and Biophysical Research Communications. 2016; 473:913-9. http://doi.org/10.1016/j.bbrc.2016.03.150
68. Gutschner T, Hämmerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, Zörnig M, MacLeod AR, Spector DL, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer research. 2013; 73:1180-9. https://doi.org/10.1158/0008-5472.can-12-2850
69. Wang J, Su L, Chen X, Li P, Cai Q, Yu B, Liu B, Wu W, Zhu Z. MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF. Biomedicine & Pharmacotherapy. 2014; 68:557-64. http://doi. org/10.1016/j.biopha.2014.04.007
70. Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F, Liu Y. TGF-β-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin Cancer Res. 2014; 20:1531-41. https://doi.org/10.1158/1078-0432.ccr-13-1455
71. Zhang R, Hardin H, Wei H, Chen J, Asioli S, Righi A, Maletta F, Sapino A, Lloyd RV. MALAT1 Long Non-coding RNA Expression in Thyroid Tissues: Analysis by In Situ Hybridization and Real-Time PCR. Endocrine Pathology. 2016: 1-6
72. Jin C, Yan B, Lu Q, Lin Y, Ma L. The role of MALAT1/ miR-1/slug axis on radioresistance in nasopharyngeal carcinoma. Tumor Biology. 2016; 37:4025-33
73. Zhang TH, Liang LZ, Liu XL, Wu JN, Su K, Chen JY, Zheng QY, Huang HZ, Liao GQ. Long non-coding RNA MALAT1 interacts with miR-124 and modulates tongue cancer growth by targeting JAG1. Oncology Reports. 2017; 37:2087
74. Liang J, Liang L, Ouyang K, Li Z, Yi X. MALAT1 induces tongue cancer cells' EMT and inhibits apoptosis through Wnt/β-catenin signaling pathway. Journal of Oral Pathology & Medicine. 2016; 46:98
75. Fang Z, Zhang S, Wang Y, Shen S, Wang F, Hao Y, Li Y, Zhang B, Zhou Y, Yang H. Long non-coding RNA MALAT-1 modulates metastatic potential of tongue squamous cell carcinomas partially through the regulation of small proline rich proteins. BMC Cancer. 2016; 16:706
76. Huang JK, Ma L, Song WH, Lu BY, Huang YB, Dong HM, Ma XK, Zhu ZZ, Zhou R. MALAT1 promotes the proliferation and invasion of thyroid cancer cells via regulating the expression of IQGAP1. Biomedicine & Pharmacotherapy. 2016; 83:1-7
77. Feng J, Tian L, Sun Y, Li D, Wu T, Wang Y, Liu M. Expression of long non-coding ribonucleic acid metastasisassociated lung adenocarcinoma transcript-1 is correlated with progress and apoptosis of laryngeal squamous cell carcinoma. Head Neck Oncol. 2012; 4:46
78. Xie L, Hu Z, Wang X, Li Z. [Expression of long noncoding RNA MALAT1 gene in human nasopharyngeal carcinoma cell lines and its biological significance]. [Article in Chinese]. Nan Fang Yi Ke Da Xue Xue Bao. 2013; 33:692-7
79. Xuan Z, Su L, Cai G, Kong L, Zhang T, Yu R, Wu Y, Mei M, Lun Z, Wang X. Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma. Scientific Reports. 2015; 5:15972
80. Yoshimoto R, Mayeda A, Yoshida M, Nakagawa S. MALAT1 long non-coding RNA in cancer. Biochimica Et Biophysica Acta. 2015; 1859:192-9
81. Ji Q, Liu X, Fu X, Zhang L, Sui H, Zhou L, Sun J, Cai J, Qin J, Ren J. Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/β-catenin signal pathway. Plos One. 2013; 8:e78700
82. Yap KL, Li S, Muñozcabello AM, Raguz S, Zeng L, Mujtaba S, Gil J, Walsh MJ, Zhou MM. Molecular Interplay of the Non-coding RNA ANRIL and Methylated Histone H3 Lysine 27 by Polycomb CBX7 in Transcriptional Silencing of INK4a. Molecular Cell. 2010; 38:662-74
83. Zou ZW, Ma C, Medoro L, Chen L, Wang B, Gupta R, Liu T, Yang XZ, Chen TT, Wang RZ. LncRNA ANRIL is upregulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stemlike cancer cells. Oncotarget. 2011; 31:61741-54. https://doi. org/10.18632/oncotarget.11437
84. Wang Y, Cheng N, Luo J. Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatininduced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma. Journal of Biochemical & Molecular Toxicology. 2017
85. Pan Y, Li C, Chen J, Zhang K, Chu X, Wang R, Chen L. The Emerging Roles of Long Noncoding RNA ROR (lincRNA-ROR) and its Possible Mechanisms in Human Cancers. Cellular Physiology & Biochemistry International Journal of Experimental Cellular Physiology Biochemistry & Pharmacology. 2016; 40:219
86. Li L, Gu M, You B, Shi S, Shan Y, Bao L, You Y. Long non-coding RNA ROR promotes proliferation, migration and chemoresistance of nasopharyngeal carcinoma. Cancer Science. 2016; 107:1215
87. Singh A, Settleman J. Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010; 29:4741-4751
88. Zhang HY, Feng L, Zhang JW, Fei W, Li W, Kang XG. Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205. Cancer Chemotherapy & Pharmacology. 2017; 79:327-37
89. Bo H, Gong Z, Zhang W, Li X, Zeng Y, Liao Q, Chen P, Shi L, Lian Y, Jing Y. Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma. Oncotarget. 2015; 6:20404-18. https://doi.org/10.18632/oncotarget.4057
90. Zeng Z, Bo H, Gong Z, Lian Y, Li X, Li X, Zhang W, Deng H, Zhou M, Peng S. AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis. Tumor Biology. 2016; 37:729
91. Zhang JY, Weng MZ, Song FB, Xu YG, Liu Q, Wu JY, Qin J, Jin T, Xu JM. Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling. International Journal of Oncology. 2016; 48:1590
92. Sun Q, Liu H, Li L, Zhang S, Liu K, Liu Y, Yang C. Long noncoding RNA-LET, which is repressed by EZH2, inhibits cell proliferation and induces apoptosis of nasopharyngeal carcinoma cell. Medical Oncology. 2015; 32:673
93. Guo J, Ma J, Zhao G, Li G, Fu Y, Luo Y. Long Non-Coding RNA LINC0086 Functions as a Tumor Suppressor in Nasopharyngeal Carcinoma By Targeting miR-214. Oncology Research. 2017; 25:1189-1197
94. Gong Z, Zhang S, Zeng Z, Wu H, Yang Q, Xiong F, Shi L, Yang J, Zhang W, Zhou Y. LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2. Plos One. 2014; 9:e110674
95. Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. The Lancet. 2016; 387:1012-24. https://doi. org/10.1016/S0140-6736(15)00055-0
96. Zhang W, Huang C, Gong Z, Zhao Y, Tang K, Li X, Fan S, Shi L, Li X, Zhang P. Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma. Journal of Molecular Histology. 2013; 44:545-54
97. Ren S, Li G, Liu C, Cai T, Su Z, Wei M, She L, Tian Y, Qiu Y, Zhang X. Next generation deep sequencing identified a novel lncRNA n375709 associated with paclitaxel resistance in nasopharyngeal carcinoma. Oncology Reports. 2016; 36:1861
98. Wang Y, Guo Q, Zhao Y, Chen J, Wang S, Jun HU, Sun Y. BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma. Oncology Letters. 2014; 8:1947
99. Zheng H, Meng W, Jiang L, Chu H, Hu J, Ning J, Li B, Dong W, Jie X. BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor. Cancer Research & Treatment. 2016; 48:698
100. Liao T, Qu N, Shi RL, Guo K, Ma B, Cao YM, Xiang J, Lu ZW, Zhu YX, Li DS. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer. Oncotarget. 2016; 8:238-247. https://doi.org/10.18632/ oncotarget.10825
101. Li R, Zhang L, Jia L, Duan Y, Li Y, Bao L, Sha N. Long Non-Coding RNA BANCR Promotes Proliferation in Malignant Melanoma by Regulating MAPK Pathway Activation. Plos One. 2014; 9:e100893
102. Jiang W, Zhang D, Xu B, Wu Z, Liu S, Zhang L, Tian Y, Han X, Tian D. Long non-coding RNA BANCR promotes proliferation and migration of lung carcinoma via MAPK pathways. Biomedecine Pharmacotherapy. 2015; 69:90-5
103. He H, Li W, Liyanarachchi S, Jendrzejewski J, Srinivas M, Davuluri RV, Nagy R, De la Chapelle A. Genetic Predisposition to Papillary Thyroid Carcinoma: Involvement of FOXE1, TSHR, and a Novel lincRNA Gene, PTCSC2. Journal of Clinical Endocrinology & Metabolism. 2014; 100:jc20142147
104. Jendrzejewski J, He H, Radomska HS, Li W, Tomsic J, Liyanarachchi S, Davuluri RV, Nagy R, De la Chapelle A. The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proceedings of the National Academy of Sciences of the United States of America. 2012; 109:8646
105. Wang Y, He H, Li W, Phay J, Shen R, Yu L, Hancioglu B, De la Chapelle A. MYH9 binds to lncRNA gene PTCSC2 and regulates FOXE1 in the 9q22 thyroid cancer risk locus. Proceedings of the National Academy of Sciences of the United States of America. 2017; 114:474-479
106. Fan M, Xinying LI, Jiang W, Huang Y, Jingdong LI, Wang Z. A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells. Experimental & Therapeutic Medicine. 2013; 5:1143
107. Carramusa L, Contino F, Ferro A, Minafra L, Perconti G, Giallongo A, Feo S. The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells. Journal of Cellular Physiology. 2007; 213:511-8
108. Zhou Q, Chen J, Feng J, Wang J. Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR). Tumor Biology. 2016; 37:3105
109. Sasaki YT, Ideue T, Sano M, Mituyama T, Hirose T. MENe/β noncoding RNAs are essential for structural integrity of nuclear paraspeckles. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106:2525-30
110. Clemson CM, Hutchinson JN, Sara SA, Ensminger AW, Fox AH, Chess A, Lawrence BJ. An Architectural Role for a Nuclear Noncoding RNA: RNA Is Essential for the Structure of Paraspeckles. Molecular Cell. 2009; 33:717
111. Chakravarty D, Sboner A, Nair SS, Giannopoulou E, Li R, Hennig S, Mosquera JM, Pauwels J, Park K, Kossai M. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nature Communications. 2011; 5:5383
112. Guo S, Chen W, Luo Y, Ren F, Zhong T, Rong M, Dang Y, Feng Z, Chen G. Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients. International Journal of Clinical & Experimental Pathology. 2015; 8:5395
113. Zhen L, Yun-Hui L, Hong-Yu D, Jun M, Yi-Long Y. Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis. Tumor Biology. 2016; 37:673
114. Chen X, Kong J, Ma Z, Gao S, Feng X. Up regulation of the long non-coding RNA NEAT1 promotes esophageal squamous cell carcinoma cell progression and correlates with poor prognosis. American Journal of Cancer Research. 2015; 5:2808
115. Li JH, Zhang SQ, Qiu XG, Zhang SJ, Zheng SH, Zhang DH. Long non-coding RNA NEAT1 promotes malignant progression of thyroid carcinoma by regulating miRNA-214. Int J Oncol. 2017; 50:708-16. https://doi. org/10.3892/ijo.2016.3803
116. Hu X, Feng Y, Zhang D, Zhao SD, Hu Z, Greshock J, Zhang Y, Yang L, Zhong X, Wang LP, Jean S, Li C, Huang Q, et al. A Functional Genomic Approach Identifies FAL1 as an Oncogenic Long Noncoding RNA that Associates with BMI1 and Represses p21 Expression in Cancer. Cancer Cell. 2014; 26:344-57
117. Jeong S, Lee J, Kim D, Seol MY, Lee WK, Jeong JJ, Nam KH, Jung SG, Shin DY, Lee EJ, Chung WY, Jo YS. Relationship of Focally Amplified Long Noncoding on Chromosome 1 (FAL1) lncRNA with E2F Transcription Factors in Thyroid Cancer. Medicine (Baltimore). 2016; 95:e2592. https://doi.org/10.1097/ md.0000000000002592
118. Pan W, Zhou L, Ge M, Zhang B, Yang X, Xiong X, Fu G, Zhang J, Nie X, Li H. Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations. Human Molecular Genetics. 2016; 25:1875
119. Yoon H, He H, Nagy R, Davuluri R, Suster S, Schoenberg D, Pellegata N, Chapelle AL. Identification of a novel noncoding RNA gene, NAMA, that is downregulated in papillary thyroid carcinoma with BRAF mutation and associated with growth arrest. International Journal of Cancer. 2007; 121:767-75
120. Goodall J, Wellbrock C, Dexter TJ, Roberts K, Marais R, Goding CR. The Brn-2 Transcription Factor Links Activated BRAF to Melanoma Proliferation. Molecular & Cellular Biology. 2004; 24:2923
121. Zhang Y, Yu S, Jiang L, Wang X, Song X. HOTAIR is a promising novel biomarker in patients with thyroid cancer. Exp Ther Med. 2017; 13:2274-8. https://doi.org/10.3892/ etm.2017.4231
122. Zhu H, Lv Z, An C, Shi M, Pan W, Zhou L, Yang W, Yang M. Onco-lncRNA HOTAIR and its functional genetic variants in papillary thyroid carcinoma. Scientific Reports. 2016; 6:31969. https://doi.org/10.1038/srep31969
123. Davies L, Welch H. Current thyroid cancer trends in the united states. JAMA Otolaryngology-Head & Neck Surgery. 2014; 140:317-22. https://doi.org/10.1001/ jamaoto.2014.1
124. Boi F, Pani F, Mariotti S. Thyroid Autoimmunity and Thyroid Cancer: Review Focused on Cytological Studies. European Thyroid Journal. 2017; 6:178-86
125. Xia S, Wang C, Ni X, Ni Z, Dong Y, Zhan W. NONHSAT076754 aids ultrasonography in predicting lymph node metastasis and promotes migration and invasion of papillary thyroid cancer cells. Oncotarget. 2016; 8:2293-2306. https://doi.org/10.18632/oncotarget.13725
126. Li JH, Zhang SQ, Qiu XG, Zhang SJ, Zheng SH, Zhang DH. Long non-coding RNA NEAT1 promotes malignant progression of thyroid carcinoma by regulating miRNA-214. International Journal of Oncology. 2016; 50: 708-716
127. Kim D, Lee WK, Jeong S, Seol MY, Kim H, Kim KS, Lee EJ, Lee J, Jo YS. Upregulation of long noncoding RNA LOC100507661 promotes tumor aggressiveness in thyroid cancer. Molecular & Cellular Endocrinology. 2016; 431:36-45
128. Ribeiro C, Correia V, Martins P, Gama FM, Lanceros-Mendez S. Proving the suitability of magnetoelectric stimuli for tissue engineering applications. Colloid Surface B. 2016; 140:430-6. https://doi.org/10.1016/j.colsurfb.2015.12.055
129. Liu S, Song L, Zeng S, Liang Z. MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells. Tumor Biology. 2016; 37:633
130. Feng T, Fang S, Wu Q, Zhang X, Xu D, Qian K, Xie Y, Wang S, Xu N, Wang Y. miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation. Oncotarget. 2016; 7:16205-16216. https://doi.org/10.18632/oncotarget.7578
131. Sun L, Li Y, Yang B. Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation, migration and invasion by depending on p53's transcriptional activity. Biochemical & Biophysical Research Communications. 2016; 478:323-9
132. Chen RP, Huang ZL, Liu LX, Xiang MQ, Li GP, Feng JL, Liu B, Wu LF. Involvement of endoplasmic reticulum stress and p53 in lncRNA MEG3-induced human hepatoma HepG2 cell apoptosis. Oncology Reports. 2016; 36:1649
133. Jia LF, Wei SB, Gan YH, Guo Y, Gong K, Mitchelson K, Cheng J, Yu GY. Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma. International Journal of Cancer. 2014; 135:2282-93
134. Zhou Y, Zhang X, Klibanski A. MEG3 noncoding RNA: a tumor suppressor. Journal of Molecular Endocrinology. 2012; 48:R45-53
135. Li Y, Ren M, Zhao Y, Lu X, Wang M, Hu J, Lu G, He S. MicroRNA-26a inhibits proliferation and metastasis of human hepatocellular carcinoma by regulating DNMT3BMEG3 axis. Oncology Reports. 2017; 37: 3527-3535
136. Huang W, Cui X, Chen J, Feng Y, Song E, Li J, Liu Y. Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition. Oncotarget. 2016; 7:62520. https://doi.org/10.18632/oncotarget.11528
137. Chaturvedi MM, Sung B, Yadav VR, Kannappan R, Aggarwal BB. NF-κB addiction and its role in cancer: 'one size does not fit all'. Oncogene. 2011; 30:1615
138. Dhamija S, Diederichs S. From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis. International Journal of Cancer. 2016; 139:269-80
139. Liu B, Sun L, Liu Q, Gong C, Yao Y, Lv X, Lin L, Yao H, Su F, Li D. A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis. Cancer Cell. 2015; 27:370
140. Bian D, Gao C, Bao K, Song G. The long non-coding RNA NKILA inhibits the invasion-metastasis cascade of malignant melanoma via the regulation of NF-κB. American Journal of Cancer Research. 2017; 7:28
141. Fang Z, Wu L, Wang L, Yang Y, Meng Y, Yang H. Increased expression of the long non-coding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis. Oral Surgery Oral Medicine Oral Pathology & Oral Radiology. 2014; 117:89-95
142. Yu J, Liu Y, Gong Z, Zhang S, Guo C, Li X, Tang Y, Yang L, He Y, Wei F. Overexpression long non-coding RNA LINC00673 is associated with poor prognosis and promotes invasion and metastasis in tongue squamous cell carcinoma. Oncotarget. 2016; 8:16621-16632. https://doi.org/10.18632/ oncotarget.14200
143. Majchrzak E, Szybiak B, Wegner A, Pienkowski P, Pazdrowski J, Luczewski L, Sowka M, Golusinski P, Malicki J, Golusinski W. Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature. Radiology and Oncology. 2014; 48:1-10
144. Almangush A, Heikkinen I, Makitie AA, Coletta RD, Laara E, Leivo I, Salo T. Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and metaanalysis. Br J Cancer. 2017; 117:856-866. https://doi. org/10.1038/bjc.2017.244
145. Yu J, Liu Y, Guo C, Zhang S, Gong Z, Tang Y, Yang L, He Y, Lian Y, Li X. Upregulated long non-coding RNA LINC00152 expression is associated with progression and poor prognosis of tongue squamous cell carcinoma. Journal of Cancer. 2017; 8:523
146. Zhang H, Zhao L, Wang YX, Xi M, Liu SL, Luo LL. Long non-coding RNA HOTTIP is correlated with progression and prognosis in tongue squamous cell carcinoma. Tumor Biology. 2015; 36:8805-9
147. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E, Chang HY. Long noncoding RNA as modular scaffold of histone modification complexes. Science (New York, NY). 2010; 329:689-93. https://doi. org/10.1126/science.1192002
148. Wu J, Xie H. Expression of long noncoding RNA-HOX transcript antisense intergenic RNA in oral squamous cell carcinoma and effect on cell growth. Tumor Biology. 2015; 36:8573-8. https://doi.org/10.1007/s13277-015-3598-5
149. Wu Y, Zhang L, Zhang L, Wang Y, Li H, Ren X, Wei F, Yu W, Liu T, Wang X, Zhou X, Yu J, Hau X. Long noncoding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma. International Journal of Oncology. 2015; 46:2586-94. https://doi.org/10.3892/ ijo.2015.2976
150. Gao L, Ren W, Zhang L, Li S, Kong X, Zhang H, Dong J, Cai G, Jin C, Zheng D. PTENp1, a natural sponge of miR-21, mediates PTEN expression to inhibit the proliferation of oral squamous cell carcinoma. Molecular Carcinogenesis. 2016; 56
151. Blanco-Aparicio C, Renner O, Leal JF, Carnero A. PTEN, more than the AKT pathway. Carcinogenesis. 2007; 28:1379
152. Yang YT, Wang YF, Lai JY, Shen SY, Wang F, Kong J, Zhang W, Yang HY. Long non-coding RNA UCA1 contributes to the progression of oral squamous cell carcinoma by regulating the WNT/β-catenin signaling pathway. Cancer Science. 2016; 107:1581
153. Xiao C, Wu CH, Hu HZ. LncRNA UCA1 promotes epithelial-mesenchymal transition (EMT) of breast cancer cells via enhancing Wnt/beta-catenin signaling pathway. European Review for Medical & Pharmacological Sciences. 2016; 20:2819
154. Liu H, Wang G, Yang L, Qu J, Yang Z, Zhou X. Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway. Plos One. 2016; 11:e0168406
155. Shang C, Guo Y, Zhang J, Huang B. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer. Cancer Chemotherapy and Pharmacology. 2016; 77:1061
156. Liu J, Shen L, Yao J, Li Y, Wang Y, Chen H, Geng P. Forkhead box C1 promoter upstream transcript, a novel long non-coding RNA, regulates proliferation and migration in basal-like breast cancer. Molecular Medicine Reports. 2014; 11:3155-9
157. Kong X, Yao J, Luo W, Feng F, Ma J, Ren Y, Wang D, Bu R. The expression and functional role of a FOXC1 related mRNA-lncRNA pair in oral squamous cell carcinoma. Molecular and Cellular Biochemistry. 2014; 394:177
158. Xia L, Huang W, Tian D, Zhu H, Qi X, Chen Z, Zhang Y, Hu H, Fan D, Nie Y. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma. Hepatology. 2013; 57:610-24
159. Zhang S, Tian L, Ma P, Sun Q, Zhang K, GuanchaoWang, Liu H, Xu B. Potential role of differentially expressed lncRNAs in the pathogenesis of oral squamous cell carcinoma. Archives of Oral Biology. 2015; 60:1581-7
160. Zhang CZ. Long non-coding RNA FTH1P3 facilitates oral squamous cell carcinoma progression by acting as a molecular sponge of miR-224-5p to modulate fizzled 5 expression. Gene. 2017; 607:47-55
161. Liu F, Liu Y, Shen J, Zhang G, Han J. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating fizzled 5 expression. Oncotarget. 2016; 7:49130-42. https://doi.org/10.18632/oncotarget.9734
162. Shuang L, Zhang S, Peng W, Chao Y, Chen S, Yang J, Wang J. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling. Gene. 2017; 608:49-57
163. Seki S, Fujiwara M, Matsuura M, Fujita S, Ikeda H, Asahina I, Ikeda T. Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors. Oral Oncol. 2011; 47:588-93. https://doi. org/10.1016/j.oraloncology.2011.04.013
164. Tang JY, Hsi E, Huang YC, Hsu NC, Chu PY, Chai CY. High LC3 expression correlates with poor survival in patients with oral squamous cell carcinoma. Hum Pathol. 2013; 44:2558-62. https://doi.org/10.1016/j. humpath.2013.06.017
165. Hamada T, Wakamatsu T, Miyahara M, Nagata S, Nomura M, Kamikawa Y, Yamada N, Batra SK, Yonezawa S, Sugihara K. MUC4: a novel prognostic factor of oral squamous cell carcinoma. Int J Cancer. 2012; 130:1768-76. https://doi.org/10.1002/ijc.26187
166. Morandi L, Gissi D, Tarsitano A, Asioli S, Monti V, Del Corso G, Marchetti C, Montebugnoli L, Foschini MP. DNA methylation analysis by bisulfite next-generation sequencing for early detection of oral squamous cell carcinoma and high-grade squamous intraepithelial lesion from oral brushing. Journal of Cranio-Maxillofacial Surgery. 2015; 43:1494-500. https://doi.org/10.1016/j.jcms.2015.07.028
167. Zhou N, Liao W, Huang Z, Hu Z, Huang W, Wang Q. Overexpression of long non-coding RNA CCAT2 predicts a poor prognosis in patients with oral squamous cell carcinoma. Int J Clin Exp Pathol. 2016; 9:110-7
168. Tang H, Wu Z, Zhang J, Su B. Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol Med Rep. 2013; 7:761-6. https://doi. org/10.3892/mmr.2012.1254
169. Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E, Wong DT. Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer Detection. Clin Cancer Res. 2009; 15:5473-7. https://doi. org/10.1158/1078-0432.ccr-09-0736
170. Peng W, Wu T, Han Z, Jin Q, He G, Yu H, Xuan L, Xin W, Tian L, Sun Y. Long noncoding RNA NEAT1 promotes laryngeal squamous cell cancer through regulating miR-107/CDK6 pathway. Journal of Experimental & Clinical Cancer Research. 2016; 35:22
171. Yang X, Xiao Z, Du X, Huang L, Du G. Silencing of the long non-coding RNA NEAT1 suppresses glioma stemlike properties through modulation of the miR-107/CDK6 pathway. Oncology Reports. 2016; 37:555-562
172. Gao W, Zhang C, Ma T, Wen S, Fu R, Zhao D, Wu Y, Wang B. Potential biomarkers and their regulatory relationships in laryngeal squamous cell carcinoma with lymph node metastasis revealed by integrating mRNA, microRNA and long non-coding RNA profiles. Int J Clin Exp Pathol. 2016; 9:5103-16
173. Kaneko S, Li G, Son J, Xu CF, Margueron R, Neubert TA, Reinberg D. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev. 2010; 24:2615-20. https://doi. org/10.1101/gad.1983810
174. Li D, Feng J, Wu T, Wang Y, Sun Y, Ren J, Liu M. Long Intergenic Noncoding RNA HOTAIR Is Overexpressed and Regulates PTEN Methylation in Laryngeal Squamous Cell Carcinoma. The American Journal of Pathology. 2013; 182:64-70. http://doi.org/10.1016/j.ajpath.2012.08.042
175. Zheng J, Xiao X, Wu C, Huang J, Zhang Y, Xie M, Zhang M, Zhou L. The role of long non-coding RNA HOTAIR in the progression and development of laryngeal squamous cell carcinoma interacting with EZH2. Acta Oto-Laryngologica. 2017; 137:90-8. https://doi.org/10.1080/00016489.2016.12 14982
176. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW. Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN. Cell. 1998; 95:29-39. http://doi.org/10.1016/S0092-8674(00)81780-8
177. Wu T, Qu L, He G, Tian L, Li L, Zhou H, Jin Q, Ren J, Wang Y, Wang J, Kan X, Liu M, Shen J, et al. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis. Oncotarget. 2016; 7:11553-66. https://doi.org/10.18632/oncotarget.7270
178. Department of Veterans Affairs Laryngeal Cancer Study Group, Wolf GT, Fisher SG, Hong WK, Hillman R, Spaulding M, Laramore GE, Endicott JW, McClatchey K, Henderson WG. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The New England journal of medicine. 1991; 324:1685-90
179. Nachalon Y, Cohen O, Alkan U, Shvero J, Popovtzer A. Characteristics and outcome of laryngeal squamous cell carcinoma in young adults. Oncol Lett. 2017; 13:1393-7. https://doi.org/10.3892/ol.2016.5528
180. Zhou H, Zhang Z, Wu Y, Zhao J. Effect of the long noncoding RNA AC007392. 4 on growth, invasion and migration for tongue squamous cell carcinoma. Int J Clin Exp Med. 2016; 9:5805-12